Want to join the conversation?
At Sept. 30, 2015, $BAC had $18.3Bil of unresolved repurchase claims, net of duplicate claims. These repurchase claims mainly relate to private-label securitizations and exclude claims in the amount of $7.4Bil at Sept. 30, 2015, net of duplicate claims, where the statute of limitations has expired without litigation being commenced.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.